Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

fluciclovine F-18 × Plasma cell × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 10 Genitourinary 6 Plasma cell 1 Head & Neck 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 238 Lenalidomide 146 daratumumab 125 Bortezomib 97 pomalidomide 81 Cyclophosphamide 77 Calcium Dobesilate 77 carfilzomib 68 belantamab mafodotin 40 Specimen Handling 40 Biopsy 39 fludarabine 38 isatuximab 34 Magnetic Resonance Spectroscopy 33 dexamethasone acetate 32 dexamethasone 21-phosphate 32 auricularum 31 Melphalan 31 ixazomib 28 talquetamab 27 iberdomide 23 elotuzumab 19 selinexor 18 fludarabine phosphate 18 Whole-Body Irradiation 18 X-Rays 13 Stem Cell Transplantation 13 venetoclax 12 Mycophenolic Acid 12 Tacrolimus 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06103838 2026-02-27

18F-Fluciclovine PET/CT in Multiple Myeloma

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡